Just In
- 3 min ago
Disha Patani Looks Breathtaking In Her Latest Glamorous Pictures
- 48 min ago
Mars Transit In Taurus 10 August 2022: Impact On 12 Zodiac Signs And Remedies
- 5 hrs ago
Daily Horoscope, 08 August 2022: Today's Horoscope Predictions For All Zodiac Signs
- 6 hrs ago
Amazon Great Freedom Sale 2022: Bring Home Boho Home Furnishing Items And Save Up To 70%
Don't Miss
- Education
CLAT 2023 application form open; Eligibility, syllabus & more.
- Sports
Commonwealth Games 2022: More Sri Lankan athletes go missing
- Finance
7 Stocks At Their 52-week Lows, Should You Buy These Stocks
- Movies
Annu Kapoor Has A Surprising Reaction On Being Asked About Aamir Khan's Laal Singh Chaddha
- News
Watch: Heartbreaking video of rhino running on a street goes viral
- Automobiles
Royal Enfield Hunter 350 Vs Honda CB350RS Vs Jawa 42 Vs TVS Ronin
- Technology
Wordle For August 8: Hints, Clues For Today’s Impossible Wordle
- Travel
Phang Nga Bay: James Bond Island
Serum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
Serum Institute of India has urged the Union government to include Covovax in the National COVID-19 Vaccination programme for inoculating those aged 12 years and above, official sources said on Tuesday, March 15. The Pune-based SII said it wants to provide Covovax to private hospitals at Rs 900 per dose plus GST and is also waiting for directions to supply the vaccine to the Centre but has not mentioned the price.
India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain conditions on March 9 and for 18 years and above on December 28.
In a letter to Health Secretary Rajesh Bhushan, Director, Government and Regulatory Affairs at SII Prakash Kumar Singh said private companies, educational institutes, social organizations, Central government organizations and Public sector undertakings are making requests for Covovax to inoculate their staffers, families and children, an official source said.
Singh is also learnt to have stated that the Pune-based firm has decided the price of Covovax for supply to private hospitals at the rate of Rs 900 plus GST per dose.
"Also, we are waiting for your kind direction for supplies of our Covovax vaccine to the Government of India," Singh mentioned in his letter.
"Under the visionary leadership of our CEO Adar C Poonawalla, we have developed, manufactured and obtained emergency use authorization from our national regulatory authority for one more world-class COVID-19 vaccine Covovax for 18 years and above on December 28, and for children in the age group of 12 to 17 years on March 9, 2022," an official source quoted Singh as having said in the letter.
He has also requested necessary changes on the CoWin portal for the addition of the Covovax vaccine to inoculate people.
The COVID vaccination for children in the age group of 12 to 14 years will begin from Wednesday. The vaccine to be given to this age group would be Corbevax manufactured by Hyderabad-based Biological E. Limited.
- wellnessGovt Panel Recommends Emergency Approval For SII's Covovax For 7-11 Year Olds
- kidsDCGI Panel To Review On Friday SII Applications For Covovax’s Use Among Kids Aged 2-7 Yrs, 7-11 Yrs
- basicsNovavax's Covid-19 Vaccine Covovax Gets Emergency Use Authorisation For 12-17 Age Group In India
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- wellnessGovt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults
- wellnessSII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults
- healthIndia-US Healthcare Collaboration In Spotlight As India Approves Two More Covid-19 Vaccines
- healthCovovax Better Booster For Covishield-Vaccinated People: Dr Shahid Jameel, Virologist
- wellnessCovovax: Everything You Need To Know About The Novavax COVID-19 Vaccine Approved For India
- healthCovovax Approval To Strengthen Immunisation Efforts In India, Lower & Middle-Income Countries: SII
- healthPanel Recommends EUA For Covid-19 Vaccines Covovax, Corbevax And Anti-Covid Pill Molnupiravir
- healthSerum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use